Llach, J.; Luzko, I.; Earl, J.; Barreto, E.; RodrÃguez-Garrote, M.; Lleixà , M.; Herrera-Pariente, C.; Fernández, G.; Munoz, J.; Bonjoch, L.;
et al. Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Cancers 2024, 16, 3779.
https://doi.org/10.3390/cancers16223779
AMA Style
Llach J, Luzko I, Earl J, Barreto E, RodrÃguez-Garrote M, Lleixà M, Herrera-Pariente C, Fernández G, Munoz J, Bonjoch L,
et al. Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Cancers. 2024; 16(22):3779.
https://doi.org/10.3390/cancers16223779
Chicago/Turabian Style
Llach, Joan, Irina Luzko, Julie Earl, Emma Barreto, Mercedes RodrÃguez-Garrote, Marc Lleixà , Cristina Herrera-Pariente, Guerau Fernández, Jenifer Munoz, Laia Bonjoch,
and et al. 2024. "Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study" Cancers 16, no. 22: 3779.
https://doi.org/10.3390/cancers16223779
APA Style
Llach, J., Luzko, I., Earl, J., Barreto, E., RodrÃguez-Garrote, M., Lleixà , M., Herrera-Pariente, C., Fernández, G., Munoz, J., Bonjoch, L., SaurÃ, T., Ausania, F., Ocaña, T., Moreno, L., Grau, E., Oriola, J., Alvarez-Mora, M. I., Herreros-Villanueva, M., CastellvÃ-Bel, S.,
... Moreira, L.
(2024). Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Cancers, 16(22), 3779.
https://doi.org/10.3390/cancers16223779
